Article
GLN2 as a key biomarker and therapeutic target: evidence from a comprehensive pan-cancer study using molecular, functional, and bioinformatic analyses
19 Nov 2024
Abstract excerpt
BACKGROUND: GNL2, a nuclear protein, is involved in ribosome production and cell cycle regulation. However, its expression and function in different types of tumors are not well understood. Comprehensive studies across multiple cancer types are needed to assess the potential of GNL2 as a diagnostic, prognostic, and immunological marker. METHODS: mRNA expression data, copy number alteration threshold data, masked...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
